Establishing Patient Access on the Road to Reimbursement: Generating Data is Key

article image
ARTICLE SUMMARY:

Device firms need to proactively implement programs to ensure that patient claims data is available from clinical trials to support future strategic efforts to establish coverage, codes, and payment for a new medical technology. This means implementing well-managed patient access programs early. By Kelli Hallas and Mike Simon.

There is a misconception that patient access to new medical technologies begins with FDA approval. In fact, patient access to emerging technologies begins at the onset of an FDA-approved clinical trial. 

×



This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: